Search research articles
Contact Us
Filters
Showing results (841-850 of 1,012) with videos related to
Page
of 102
Sort By:
Blood
|
March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability
Barbara Sarina, Luca Castagna, Lucia Farina, et al.
European Journal of Haematology
|
November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
Francesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Maturitas
|
November 20, 2024
Clinical and histomorphometric evaluation of the vagina following treatment with CO<sub>2</sub> laser, radiofrequency, and promestriene for genitourinary syndrome of menopause in breast cancer survivors on adjuvant therapy
Gabriela C Cantarelli, Ana M H M Bianchi-Ferraro, Chayanne Dedonatto, et al.
Bone Marrow Transplantation
|
April 26, 2020
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)
A Olivieri, G Mancini, J Olivieri, et al.
Lancet (London, England)
|
December 15, 2010
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Michele Cavo, Paola Tacchetti, Francesca Patriarca, et al.
Bone Marrow Transplantation
|
January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
E Todisco, F Ciceri, C Boschini, et al.
Blood
|
June 19, 2013
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results
Francesca Gay, Valeria Magarotto, Claudia Crippa, et al.
Bone Marrow Transplantation
|
April 15, 2020
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation
Luciano J Costa, Simona Iacobelli, Marcelo C Pasquini, et al.
Placenta
|
April 9, 2025
Intercellular adhesion molecule (ICAM)-1 is required to control Toxoplasma gondii infection in uterine tissues and establish a successful gestation in a murine model of congenital toxoplasmosis
Rafaela José da Silva, Marcos Paulo Oliveira Almeida, Angelica Oliveira Gomes, et al.
Blood
|
January 27, 2023
Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience
Bruno Fattizzo, Marta Bortolotti, Norma N Fantini, et al.
Page
of 102
Search research articles
Search
Showing results (841-850 of 1,012) with videos related to
Sort By:
Page
of 102
Blood
|
March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability
Barbara Sarina, Luca Castagna, Lucia Farina, et al.
European Journal of Haematology
|
November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
Francesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Maturitas
|
November 20, 2024
Clinical and histomorphometric evaluation of the vagina following treatment with CO<sub>2</sub> laser, radiofrequency, and promestriene for genitourinary syndrome of menopause in breast cancer survivors on adjuvant therapy
Gabriela C Cantarelli, Ana M H M Bianchi-Ferraro, Chayanne Dedonatto, et al.
Bone Marrow Transplantation
|
April 26, 2020
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)
A Olivieri, G Mancini, J Olivieri, et al.
Lancet (London, England)
|
December 15, 2010
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Michele Cavo, Paola Tacchetti, Francesca Patriarca, et al.
Bone Marrow Transplantation
|
January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
E Todisco, F Ciceri, C Boschini, et al.
Blood
|
June 19, 2013
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results
Francesca Gay, Valeria Magarotto, Claudia Crippa, et al.
Bone Marrow Transplantation
|
April 15, 2020
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation
Luciano J Costa, Simona Iacobelli, Marcelo C Pasquini, et al.
Placenta
|
April 9, 2025
Intercellular adhesion molecule (ICAM)-1 is required to control Toxoplasma gondii infection in uterine tissues and establish a successful gestation in a murine model of congenital toxoplasmosis
Rafaela José da Silva, Marcos Paulo Oliveira Almeida, Angelica Oliveira Gomes, et al.
Blood
|
January 27, 2023
Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience
Bruno Fattizzo, Marta Bortolotti, Norma N Fantini, et al.
Page
of 102